Aller/Sns 6 X Tablet is a Health Canada–registered human drug (DIN 02233394) held by Botanical Laboratories Inc., containing Sticta Pulmonaria. Health Canada lists its status as Cancelled Post Market (status date 01 Jan 2006). Nexara Health has matched 10 registrations of Sticta Pulmonaria across 2 other regulated markets.
Health Canada registration
| DIN | 02233394 |
|---|---|
| Brand name | Aller/Sns |
| Active ingredient | Sticta Pulmonaria |
| Strength | 6 X |
| Dosage form | Tablet |
| Route | Oral |
| Company | Botanical Laboratories Inc. |
| Status | Cancelled Post Market — 01 Jan 2006 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Sticta Pulmonaria registered in other markets
10 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Sticta pulmonaria | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Sticta pulmonaria | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United States | Sticta Pulmonaria | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sticta Pulmonaria | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sticta Pulmonaria | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sticta Pulmonaria | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sticta Pulmonaria | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sticta Pulmonaria | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sticta Pulmonaria | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Sticta Pulmonaria | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Sticta Pulmonaria worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Aller/Sns (DIN 02233394) marketed in Canada?
No. Health Canada lists DIN 02233394 as Cancelled Post Market as of 01 Jan 2006.
Who holds the Canadian licence for this product?
Botanical Laboratories Inc. is the company of record in the Health Canada Drug Product Database.
Is Sticta Pulmonaria registered outside Canada?
Yes — Nexara Health has matched 10 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02233394, status date 2006-01-01; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02233394, status date 2006-01-01; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02233394, status date 2006-01-01; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.